Best Practices' Study Examines How Pharmaceutical Industry is Navigating the New Scientific Publications Landscape | Markets Insider

CHAPEL HILL, N.C., Jan. 12, 2018 /PRNewswire/ -- Biopharmaceutical organizations rely on scientific publications to inform the medical community about critical clinical trial data. It is the data from early phases of drug development that critical stakeholders such as physicians and payers learn about new products. and the information serves as the building blocks for how a new product will be positioned in the marketplace....

The study found that open access platforms are gaining popularity for publication processes; 44% of companies in the study believe such platforms will impact publication strategy going forward. Part of the allure for open access platforms is they make information readily available to physicians and patients alike. In the wake of open access platforms, companies foresee an impact on areas such as journal selection, publication approval and delivery, and speed of data disclosure.

In particular, this 85-page study provides benchmarks around publications structure and leadership; staffing and budget levels; publication strategy creation and data delivery; publication channel utilization across product lifecycle; and measuring publication effectiveness...."